¿Cómo comparar fármacos biológicos?
Author:
Publisher
Elsevier BV
Subject
Rheumatology
Reference63 articles.
1. Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response;Emery;Ann Rheum Dis.,2011
2. Review article: The expanding role of biological agents in the treatment of inflammatory bowel disease —focus on selective adhesion molecule inhibition;Rutgeerts;Aliment Pharmacol Ther,2003
3. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: Patient-reported outcomes of the CHARM trial;Loftus;Am J Gastro,2008
4. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: Results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis;Revicki;Br J Dermatol,2008
5. Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis;Van der Heijde;Art Res Ther,2009
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rose Bengal Labeled Bovine Serum Albumin for Protein Transport Imaging in Subcutaneous Tissues Using Computed Tomography and Fluorescence Microscopy;Bioconjugate Chemistry;2024-06-14
2. Avances y perspectivas actuales en recursos y estrategias terapéuticas: fármacos biológicos;Medicine - Programa de Formación Médica Continuada Acreditado;2021-05
3. Atributos del fármaco antirreumático modificador de la enfermedad biológico en las primeras líneas de tratamiento de la artritis reumatoide. Proyecto ACORDAR 2015;Reumatología Clínica;2018-03
4. Biologic Disease-modifying Antirheumatic Drug Attributes in the First Lines of Treatment of Rheumatoid Arthritis. 2015 ACORDAR Project;Reumatología Clínica (English Edition);2018-03
5. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial;The Lancet;2017-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3